Long-term follow-up of recovered MPN patients with COVID-19

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Barbui, Tiziano
• dc.contributor.author Andrade-Campos, Marcio
• dc.contributor.author Bellosillo Paricio, Beatriz
• dc.contributor.author Rambaldi, Alessandro
• dc.date.accessioned 2022-07-19T06:36:30Z
• dc.date.available 2022-07-19T06:36:30Z
• dc.date.issued 2021
• dc.description.sponsorship The study was supported by a research grant by the COVID “3×1 project”, BREMBO S.p.A., Bergamo, Italy (TB) and by AIRC 5×1000 call “Metastatic disease: the key unmet need in oncology” to MYNERVA project, #21267 (MYeloid NEoplasms Research Venture AIRC). A detailed description of the MYNERVA project is available at https://progettomynerva.it (AMV, PG). The study was also supported by HARMONY PLUS, which is funded through the Innovative Medicines Initiative (IMI), Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. The HARMONY Alliance has received funding from IMI 2 Joint Undertaking and is listed under grant agreement No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
• dc.format.mimetype application/pdf
• dc.identifier.citation Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Rossi G, et al. Long-term follow-up of recovered MPN patients with COVID-19.Blood Cancer J. 2021 Jun 16; 11(6): 115. DOI: 10.1038/s41408-021-00509-0
• dc.identifier.doi http://dx.doi.org/10.1038/s41408-021-00509-0
• dc.identifier.issn 2044-5385
• dc.identifier.uri http://hdl.handle.net/10230/53758
• dc.language.iso eng
• dc.publisher Nature Research
• dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/945406
• dc.rights This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword COVID-19 - complications
• dc.subject.keyword COVID-19 - mortality
• dc.subject.keyword Leukemia
• dc.subject.keyword Myeloid
• dc.subject.keyword Lymphoma, non-Hodgkin
• dc.subject.keyword Myeloproliferative disorders
• dc.title Long-term follow-up of recovered MPN patients with COVID-19
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion